Association of cannabis use with opioid outcomes among opioid-dependent youth

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 342-345

  Hill, Kevin P ^a,b   Bennett, Heather E ^a   Griffin, Margaret L ^a,b   Connery, Hilary S ^a,b   Fitzmaurice, Garrett M ^a,b   Subramaniam, Geetha ^c   Woody, George E ^d   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescent substance abuse; Buprenorphine; Cannabis use; Opioid dependence

Indexed keywords

BUPRENORPHINE PLUS NALOXONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS SMOKING; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DETOXIFICATION; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; SELF REPORT; SOCIAL PSYCHOLOGY;

CANNABIS;

ADOLESCENT SUBSTANCE ABUSE; BUPRENORPHINE; CANNABIS USE; OPIOID DEPENDENCE;

ADULT; BUPRENORPHINE; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MARIJUANA ABUSE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE DETECTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881663571     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.02.030     Document Type: Article

References (23)

1. Bracken B.K., Rodolico J., Hill K.P. Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey. Subst. Abuse 2013, (Epub ahead of print 04 Feb 2013). 10.1080/08897077.2013.770424.
2. Budney A.J., Bickel W.K., Amass L. Marijuana use and treatment outcome among opioid-dependent patients. Addiction 1998, 93:493-503.
3. Church S.H., Rothenberg J.L., Sullivan M.A., Bornstein G., Nunes E.V. Concurrent substance abuse and outcome in combined behavioral and naltrexone therapy for opiate dependence. Am. J. Drug Alcohol Abuse 2001, 27:441-452.
4. de Graaf R., Radovanovic M., van Laar M., Fairman B., Degenhardt L., Aguilar-Gaxiola S., Bruffaerts R., de Girolamo G., Fayyad J., Gureje O., Haro J.M., Huang Y., Kostychenko S., Lepine J., Matschinger H., Mora M.E.M., Neumark Y., Ormel J., Posada-Villa J., Stein D.J., Tachimori H., Wells J.E., Anthony J.C. Early cannabis use and estimated risk of later onset of depression spells Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am. J. Epidemiol. 2010, 172:149-159.
5. DuPont R.L., Saylor K.E. Marijuana and benzodiazepine in patients receiving methadone maintenance treatment. JAMA 1989, 261:3409.
6. Epstein D.H., Preston K.L. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? A review of past findings, and more evidence against. Addiction 2003, 98:269-279.
7. Gruber S.A., Sagar K.A., Dahlgren M.K., Racine M., Lukas S.E. Age of onset of marijuana use and executive function. Psychol. Addict. Behav. 2011, 26:496-506.
8. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2011 2012, Institute for Social Research The University of Michigan, Ann Arbor.
9. Kuepper R., van Os J., Lieb R., Wittchen H., Hofler M., Henquet C. Continued cannabis use and risk of psychosis and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011, (Epub ahead of print).
10. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis. Arch. Gen. Psychiatry 2011, 68:555-561.
11. Marsch L.A., Bickel W.K., Badger G.J., Stothart M.E., Quesnel K.J., Stanger C., Brooklyn J. Comparison of pharmacological treatments for opioid-dependent adolescents. Arch. Gen. Psychiatry 2005, 62:1157-1164.
12. McGrath J., Welham J., Scott J., Varghese D., Degenhardt L., Hayatbakash M.R., Alati R., Williams G.M., Bor W., Najman J.M. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch. Gen. Psychiatry 2010, 67:440-447.
13. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., Muller J.E. Triggering myocardial infarction by marijuana. Circulation 2001, 103:2805-2809.
14. Nirenberg T.D., Liepman M.R., Cellucci T., Swift R.M., Sirota A.D. Cannabis versus other illicit drug use among methadone maintenance patients. Psychol. Addict. Behav. 1996, 10:222-227.
15. Pope H.G., Gruber A.J., Hudson J.I., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001, 58:909-915.
16. Raby W.F., Carpenter K.M., Rothenberg J., Brooks A.C., Jiang H., Sullivan M., Bisaga A., Comer S., Nunes E.V. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am. J. Addict. 2009, 18:301-308.
17. Saxon A.J., Calsyn D.A., Greenberg D., Blaes P., Haver V.M., Stanton V. Urine screening for marijuana among methadone-maintained patients. Am. J. Addict. 1993, 2:207-211.
18. Subramaniam G.A., Stitzer M.L., Woody G., Fishman M.J., Kolodner K. Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend. 2009, 99:141-149.
19. Subramaniam G.A., Warden D., Minhajuddin A., Fishman M.J., Stitzer M.L., Adinoff B., Trivedi M., Weiss R.D., Potter J., Poole S.A., Woody G.E. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50:1120-1128.
20. Substance Abuse and Mental Health Services Administration, 2008. Treatment Episode Data Set (TEDS): 1996-2006. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-43, DHHS Publication No. (SMA) 08-4347, Rockville, MD.
21. Tashkin D.P. Smoked marijuana as a cause of lung injury. Monaldi Arch. Chest Dis. 2005, 63:92-100.
22. Wasserman D.A., Weinstein M.G., Havassy B.E., Hall S.M. Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend. 1998, 52:183-192.
23. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., Patkar A., Publicker M., McCain K., Potter J.S., Forman R., Vetter V., McNicholas L., Blaine J., Lynch K.G., Fudala P. Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth. JAMA 2008, 300:2003-2011.